InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,884.10
(
0.15%
)
Post# of 20689
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

floblu14

Send PM Follow Ignore
Followers 22
Posts 3642
Boards Moderated 0
Alias Born 07/20/2006

floblu14

Re: floblu14 post# 15622

Friday, 06/10/2016 3:23:11 PM

Friday, June 10, 2016 3:23:11 PM

Post# of 20689
POSTER - EULAR Congress, London, June 8-11, 2016

A Randomised, Double-blind, Three-arm, Parallel-group, Single-dose Study to Compare the Pharmacokinetics, Safety, Tolerability, and Immunogenicity of M923 (a candidate biosimilar of adalimumab), versus US-sourced Humira and EU-sourced Humira in Healthy Subjects, EULAR 2016

http://www.momentapharma.com/docs/poster_EULAR-2016-Baxalta-M923-final.pdf
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!